As part of Allergan’s ongoing commitment to patients, we wanted to provide information related to our BIOCELL^® textured breast implant voluntary recall in cooperation with Health Canada.

What does the recall mean and why is it happening?

Allergan Canada has made the decision to voluntarily recall textured breast implants from the Canadian market as a result of Health Canada’s suspension of the BIOCELL^® textured implant licence.

As part of this voluntary recall, any unused BIOCELL^® saline-filled and silicone-filled textured breast implants (medical device licences 3112, 72262, 72263, 87277 and 87279) will be removed from the Canadian market and no longer be sold.

NOTE: NATRELLE^® smooth implants and tissue expanders are not impacted by this licence suspension and voluntary recall.

Patient safety is Allergan’s highest priority. This decision will raise many questions for Canadians who have textured breast implants. Patients are advised to have a thorough discussion with their plastic surgeon about the risks and benefits of their implant type should they have any concerns with their implants.

We encourage you to speak with your plastic surgeon should you have questions or concerns regarding your implants. A list of textured breast implant patient questions can be found here.